Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data
- PMID: 28007199
- DOI: 10.1016/j.jcin.2016.10.008
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data
Abstract
Objectives: The authors undertook a patient-level meta-analysis to compare long-term outcomes after coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in 3,280 patients with left main or multivessel coronary artery disease (CAD).
Background: The relative efficacy and safety of CABG versus PCI with DES for left main or multivessel CAD remain controversial.
Methods: Data were pooled from the BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease), PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery vs. Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trials. The primary outcome was a composite of all-cause death, myocardial infarction, or stroke.
Results: The median follow-up was 60 months, and follow-up was completed for 96.2% of patients. The rate of primary outcome was significantly lower with CABG than with PCI (13.0% vs. 16.0%; hazard ratio [HR]: 0.83; 95% confidence interval [CI]: 0.69 to 1.00; p = 0.046). The difference was mainly driven by reduction in myocardial infarction (HR: 0.46; 95% CI: 0.33 to 0.64; p < 0.001). There was significant interaction between treatment effect and types of CAD, showing CABG to be superior compared with PCI with DES in patients with multivessel CAD (p = 0.001), but no between-group difference in those with left main CAD (p = 0.427). The rates for all-cause death and stroke were similar between the 2 groups. By contrast, the need for repeat revascularization was significantly lower in the CABG group compared with the PCI group.
Conclusions: CABG, as compared with PCI with DES, reduced long-term rates of the composite of all-cause death, myocardial infarction, or stroke in patients with left main or multivessel CAD. The advantage of CABG over PCI with DES was particularly pronounced in those with multivessel CAD.
Keywords: coronary artery bypass graft surgery; drug-eluting stent(s); left main coronary artery disease; multivessel coronary artery disease.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Coronary Bypass Surgery Versus Percutaneous Coronary Intervention in Left Main and Multivessel Disease: Incremental Data-How Do We Apply It?JACC Cardiovasc Interv. 2016 Dec 26;9(24):2490-2492. doi: 10.1016/j.jcin.2016.11.011. JACC Cardiovasc Interv. 2016. PMID: 28007200 No abstract available.
Similar articles
-
Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.JACC Cardiovasc Interv. 2017 Jul 24;10(14):1415-1424. doi: 10.1016/j.jcin.2017.04.037. JACC Cardiovasc Interv. 2017. PMID: 28728654
-
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071. J Am Coll Cardiol. 2018. PMID: 30025574
-
Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.Circ Cardiovasc Interv. 2017 May;10(5):e005027. doi: 10.1161/CIRCINTERVENTIONS.117.005027. Circ Cardiovasc Interv. 2017. PMID: 28495897
-
Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.JACC Cardiovasc Interv. 2014 May;7(5):497-506. doi: 10.1016/j.jcin.2013.12.202. Epub 2014 Apr 16. JACC Cardiovasc Interv. 2014. PMID: 24746647 Review.
-
Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.Cardiovasc Revasc Med. 2018 Sep;19(6):671-678. doi: 10.1016/j.carrev.2018.01.003. Epub 2018 Jan 5. Cardiovasc Revasc Med. 2018. PMID: 29396239 Review.
Cited by
-
Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial.Anatol J Cardiol. 2019 Feb;21(2):83-90. doi: 10.14744/AnatolJCardiol.2018.21447. Anatol J Cardiol. 2019. PMID: 30694800 Free PMC article. Clinical Trial.
-
The epidemiology of coronary artery bypass surgery in a community hospital: A comparison between 2 periods.Medicine (Baltimore). 2019 Mar;98(13):e15059. doi: 10.1097/MD.0000000000015059. Medicine (Baltimore). 2019. PMID: 30921236 Free PMC article.
-
Peripheral Artery Tonometry Reveals Impaired Endothelial Function before Percutaneous Coronary Intervention in Patients with Periprocedural Myocardial Injury.J Interv Cardiol. 2021 Jul 15;2021:5598120. doi: 10.1155/2021/5598120. eCollection 2021. J Interv Cardiol. 2021. PMID: 34354549 Free PMC article.
-
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study.Clin Res Cardiol. 2021 Oct;110(10):1543-1553. doi: 10.1007/s00392-020-01802-x. Epub 2021 Jan 30. Clin Res Cardiol. 2021. PMID: 33517534 Free PMC article. Clinical Trial.
-
Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease.Ann Cardiothorac Surg. 2018 Jul;7(4):506-515. doi: 10.21037/acs.2018.05.17. Ann Cardiothorac Surg. 2018. PMID: 30094215 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous